Bill Holland Purchases 32,522 Shares of CLS Holdings plc (LON:CLI) Stock

CLS Holdings plc (LON:CLIGet Free Report) insider Bill Holland acquired 32,522 shares of CLS stock in a transaction dated Thursday, August 14th. The stock was bought at an average price of GBX 61 ($0.83) per share, with a total value of £19,838.42 ($26,888.61).

CLS Trading Up 0.7%

Shares of CLI stock opened at GBX 61.70 ($0.84) on Friday. CLS Holdings plc has a 52-week low of GBX 56.80 ($0.77) and a 52-week high of GBX 101.40 ($1.37). The company has a debt-to-equity ratio of 123.30, a quick ratio of 0.59 and a current ratio of 0.73. The firm has a market capitalization of £245.87 million, a PE ratio of -1.19 and a beta of 1.01. The stock has a fifty day simple moving average of GBX 66.59 and a two-hundred day simple moving average of GBX 66.54.

CLS (LON:CLIGet Free Report) last issued its quarterly earnings results on Wednesday, August 13th. The company reported GBX (6.10) (($0.08)) earnings per share (EPS) for the quarter. CLS had a negative return on equity of 23.42% and a negative net margin of 134.11%. On average, analysts predict that CLS Holdings plc will post 10.0104167 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Berenberg Bank reiterated a “buy” rating and issued a GBX 100 ($1.36) price target on shares of CLS in a research note on Wednesday.

View Our Latest Stock Report on CLS

CLS Company Profile

(Get Free Report)

We are a commercial property investment company with a £2.1bn portfolio listed on the Premium Main Market on the London Stock Exchange, specialising in future-focused office space in the UK, Germany and France. Through geographical diversification, local expertise and an active management approach, we transform office properties into sustainable, modern spaces that help our tenants’ businesses to grow.

Recommended Stories

Insider Buying and Selling by Quarter for CLS (LON:CLI)

Receive News & Ratings for CLS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CLS and related companies with MarketBeat.com's FREE daily email newsletter.